Adverse reactions to Duvelisib

Duvelisib (Duvelisib) is an anti-cancer drug used to treat lymphoma and leukemia. Its use may cause a series of adverse reactions. These adverse reactions can affect patients' quality of life, so doctors and patients need to pay close attention to these potential risks when using duveliside. The following are some common adverse reactions of duveliside:

1. Infection: Infection is one of the common adverse reactions when using duveliset. This may include bacterial, viral or fungal infections. Patients should pay close attention to signs of infection during treatment, such as fever, sore throat, cough, shortness of breath, and urgency to urinate. Any infection requires prompt treatment.

2. Nausea and vomiting: Nausea and vomiting are common gastrointestinal adverse reactions. These symptoms may affect a patient's appetite and diet, leading to weight loss and dehydration. Your doctor can recommend medications to reduce these symptoms.

3. Diarrhea: Diarrhea is another common gastrointestinal adverse reaction. Patients may experience frequent diarrhea, which may lead to dehydration and electrolyte imbalance. Dietary management and medications can help control diarrhea.

4. Skin reactions: Skin itching, rash, dryness, and inflammation may occur during use of duvelised. These skin reactions may cause discomfort, but your doctor can recommend appropriate skin care methods and medications to relieve symptoms.

5. Fatigue: Patients taking duvelisel often experience fatigue and weakness. This fatigue may affect the patient's ability to perform daily activities and activities.

6. Liver damage: Duvelised may have adverse effects on the liver, leading to liver damage. Patients will need to receive regular liver function monitoring during treatment, as well as physician advice to manage this adverse reaction.

7. Intestinal inflammation: The use of duvelisel may cause intestinal inflammation, including abdominal pain, diarrhea, bloating, etc. Patients need to inform their doctor of any symptoms of intestinal inflammation so they can be managed promptly.

8. Hypertension: Patients taking duvelised may experience high blood pressure, which requires regular monitoring and management.

9. Pulmonary arterial hypertension (PAH): PAH is a disease of the blood vessels in the lungs that may be caused by duvelised. Patients need to pay attention to respiratory and heart-related symptoms, such as shortness of breath and chest pain.

10. Autoimmune diseases: The use of duvelisel may lead to the occurrence of autoimmune diseases, such as autoimmune hemolytic anemia and other autoimmune diseases. Patients need to pay close attention to related symptoms, such as anemia and bleeding.

It is important to emphasize that the severity and frequency of adverse reactions vary between patients. Physicians will assess the risk of adverse reactions based on the patient's specific situation and take necessary steps to reduce discomfort. Patients should receive regular medical monitoring while using duveliset and promptly communicate with their doctor about any disease symptoms or discomfort in order to receive optimal treatment and support. If serious adverse reactions occur, your doctor may adjust your treatment plan or interrupt your use of duvelised. When using this medication, close collaboration between doctor and patient is crucial to ensure safe and effective treatment.

The original drug of Duvelisel Capsules has been launched in China, but it is not covered by medical insurance. Patients can buy it domestically at a price of more than 20,000 yuan. For specific prices, please consult the local hospital pharmacy.